Should Dynamic Drug Pricing be Incorporated into Cost-Effectiveness Analyses? – Healthcare Economist
Cost-effectiveness analyzes (CEA) aim to examine how new healthcare technologies impact health outcomes and costs throughout a patient's life. While it is ...
According to an article by Miljković et al. (2023)the answer is 'No'. The authors examine cancer treatments with FDA ...